Company profile: Magnolia Medical
1.1 - Company Overview
Company description
- Provider of blood culture contamination reduction solutions, including Steripath Initial Specimen Diversion Device and Steripath Micro to divert and sequester initial blood draws, the Mission Control educational platform offering best-practice collection training, and a clinical performance guarantee of at least 50% contamination reduction or money back.
Products and services
- Steripath Initial Specimen Diversion Device: Diversion-based device that diverts and sequesters the initial blood draw before specimen collection to lower blood culture contamination rates during diagnostic testing
- Clinical Performance Guarantee: Outcome-based commitment promising at least a 50% reduction in blood culture contamination rates when using Steripath devices, or a full refund for customers
- Steripath Micro: Micro-volume diversion device that diverts a smaller initial blood draw to reduce contamination in blood cultures, supporting improved accuracy in diagnostic blood culture testing
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Magnolia Medical
ImmunoVision
HQ: United States
Website
- Description: Provider of proprietary diagnostic reagents and test kits, specializing in their manufacture and marketing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ImmunoVision company profile →
OptraScan
HQ: United States
Website
- Description: Provider of digital pathology slide scanners and imaging solutions that convert glass slides into high-resolution images, with integrated software for image management and telepathology. Offerings include high-speed whole slide scanners, compact low-volume and 15-slide brightfield systems, an AI-enabled cytology scanner with real-time analysis, and a frozen section scanner with live remote review.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OptraScan company profile →
Isolere Bio
HQ: United States
Website
- Description: Provider of biotherapeutic purification solutions, offering IsoTag Reagent Technology that combines phase separation with affinity ligands to purify biologics, IsoTag AAV for downstream purification of AAV serotypes, IsoTag LV for capturing and concentrating lentivirus, custom development of tailored purification solutions, and pipeline programs for adenovirus, mRNA, and pDNA purification.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Isolere Bio company profile →
BioDtech
HQ: United States
Website
- Description: Provider of reagents and systems for the detection, neutralization, and removal of endotoxin for researchers in bioresearch and bioprocess markets, offering detection solutions including EndoDtec-F to uncover bacteria in environmental samples, injectable drugs, and medical devices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioDtech company profile →
Xpand Biotech
HQ: The Netherlands
Website
- Description: Provider of bone repair and regeneration products based on proprietary surface science technology, with in-house R&D, manufacturing, and clean room facilities; based in Bilthoven, The Netherlands.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Xpand Biotech company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Magnolia Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Magnolia Medical
2.2 - Growth funds investing in similar companies to Magnolia Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Magnolia Medical
4.2 - Public trading comparable groups for Magnolia Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →